Mr. Speaker, the auditor general reported today that the board which sets the prices Canadians pay for patented prescription drugs relies essentially on information provided by the very drug companies that sell those drugs without checking the facts and without regard for the impact on consumers.
When will the government begin pricing drugs in the interests of Canadians instead of in the interests of international drug conglomerates?
Will the Minister of Health specifically take steps to ensure that drug pricing decisions are transparent and at least that information from the drug companies is checked for accuracy?